gp130: a promising drug target for cancer therapy.

gp130: a promising drug target for cancer therapy.

Item
http://www.wikidata.org/entity/Q38149939
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesRepositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapyInterleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.STAT3 in the systemic inflammation of cancer cachexia.From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.IL-11 signaling as a therapeutic target for cancer.Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling.
P2860

gp130: a promising drug target for cancer therapy.

Item
http://www.wikidata.org/entity/Q38149939
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
gp130: a promising drug target for cancer therapy.
@en
type
label
gp130: a promising drug target for cancer therapy.
@en
prefLabel
gp130: a promising drug target for cancer therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
gp130: a promising drug target for cancer therapy.
@en
P2093
P2860
P304
P31
P356
10.1517/14728222.2013.830105
P407
P433
P478
P577
P5875
P698